Bellerophon Therapeutics (BLPH, $0.05) was a top weekly loser, falling to $0.05 per share. Of the 915 stocks analyzed in the Biotechnology Industry throughout the week of April 24 - May 1, of them () exhibited an Uptrend while of them () were in a Downtrend.